Target intelligence / Profile preview

Nitric oxide synthase 2 pseudogene 2 (NOS2P2)

Target
NOS2P2
Molecular classification
Pseudogene
01

Overview

Nitric oxide synthase 2 pseudogene 2 (NOS2P2) is a pseudogene related to the gene encoding inducible nitric oxide synthase (NOS2, iNOS). Pseudogenes typically arise due to duplication or mutation of functional genes and are generally not translated into functional proteins. While some pseudogenes have emerging roles in regulating gene expression via antisense RNA or truncated dominant-negative proteins, NOS2P2 is not known to encode a functional protein, nor is it considered a therapeutic target or disease biomarker. NOS2P2 may be referenced in genetics research due to its relationship to NOS2. The canonical functional target in clinical and drug development contexts is nitric oxide synthase, inducible (NOS2/iNOS).

Other names
NOS2B
02

Mechanism of action

None for NOS2P2, as it is a pseudogene and not a drug target. Mechanisms for NOS2 inhibitors (e.g., reduced NO production) do not apply.

03

Biological functions

Potential regulation of gene expression by antisense RNA or by dominant negative protein interactions (speculative and based on limited evidence for some NOS pseudogenes in regulation of NOS2 activity, not well-established for NOS2P2 specifically)No known direct biological function as an active enzyme or receptor.
04

Disease associations

None established. Active NOS2 (iNOS) is implicated in several diseases, but NOS2P2 itself has not been directly linked to disease
05

Safety considerations

None known, as NOS2P2 itself is not targeted therapeutically.Safety concerns described for NOS2-targeted drugs do not apply.
06

Interacting drugs

None. Drugs interact with active NOS2, not NOS2P2.
07

Biomarkers

None known.

Beyond the preview

Go deeper on Nitric oxide synthase 2 pseudogene 2 (NOS2P2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Nitric oxide synthase 2 pseudogene 2 (NOS2P2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call